Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality may offer Drug-Free relief for menopause symptoms

NCT ID NCT07044284

Symptom relief Sponsor: London Metropolitan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This pilot study tests whether an immersive virtual reality experience using fractal mindfulness can help women with menopause symptoms. Participants will use VR to practice mindfulness, and researchers will measure changes in symptoms, sexual function, well-being, and cognitive mindfulness. The study also tracks pulse rate and brain activity to see if the intervention has a calming effect.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Immersive virtual reality using fractal mindfulness software
What this could lead to
If effective, this approach could offer a drug-free way to manage menopause symptoms and improve quality of life.
What could go wrong
This is a small pilot study, so results may not apply broadly. VR may cause discomfort or side effects in some users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Feb 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Must have perceived peri or menopausal symptoms * Must have normal or corrected to normal hearing and vision * Must be 18 years or older * Must have used virtual reality before with no side effects * Must have a pulse rate of 60 to 80 beats per minute * Must NOT experience seizures * Must NOT have coordination difficulties Exclusion Criteria: * Do not have peri or menopausal symptoms * Have coordination difficulties * Report having claustrophobia * Pulse rate higher than 80 at rest * Have sensitivities to flashing lights * Are prone to migraine * Have seizures Are younger than 18 years old

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopause are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Menopause

Contacts and locations

Locations

  • School of Social Science and Professions

    London, N7 8DB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.